Cleveland Clinic Taussig Cancer Institute is a clinical research site located in Cleveland, Ohio, United States 44195.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Cleveland Clinic Taussig Cancer Institute has participated in 23 clinical trials with 7 currently active.
Therapeutic areas: Multiple Myeloma, Solid Tumor, Adult Soft Tissue Sarcoma.
Sponsors: Pfizer, Lamassu Bio Inc, Mount Sinai Hospital, Canada.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Cleveland Clinic Taussig Cancer Institute has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cleveland Clinic Taussig Cancer Institute has 23 clinical trials on record, with 7 currently active. Their work covers Multiple Myeloma, Solid Tumor, Adult Soft Tissue Sarcoma.
Yes — Cleveland Clinic Taussig Cancer Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.